Valence 로고
인기
로그인
Loading data for DMIIR — first visit, this takes a few seconds.

관심목록에 추가

Drugs Made In America Acq...

NasdaqGM: DMIIR · 실시간 가격 · USD
0.10
+0.00 (0.00%)
종가 기준: Aug 17, 2026, 8:00 PM

Drugs Made In America Acquisition II Corp. (DMIIR) Stock Price, Analysis & Data

0.00%

데이터 없음

매수호가n/a
시가총액n/a
매출 (ttm)n/a
순이익 (ttm)8.58M
베타n/a
EPS (ttm)n/a
P/E (ttm)n/a
선행 P/En/a
P/B (ttm)-0.36
P/S (ttm)n/a
Earnings Daten/a
매도호가n/a
거래량83
평균 거래량 (20일)
시가0.09
전일 종가0.10
일중 범위0.10 - 0.10
52주 범위0.10 - 0.10
애널리스트n/a
목표주가n/a
배당n/a
배당락일n/a

DMIIR 소개

Drugs Made In America Acquisition II Corp. does not have significant operations. The company focuses on effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or other similar business combination with one or more businesses. It intends to source and evaluate companies focused on the pharmaceutical sector. Drugs Made In America Acquisition II Corp. was incorporated in 2024 and is based in New York...

[더 보기]
산업
섹터
IPO 일자 n/a
직원 수 n/a
상장 거래소 NasdaqGM
티커 DMIIR
전체 기업 정보

재무 실적

undefined년 Drugs Made In America Acquisition II의 매출은 n/a로, 전년 n/a 대비 undefined% 증가했습니다. 순이익은 n/a로, undefined% 증가했습니다.

재무제표
news image

5개월 전 · Motley Fool

NexGen Energy’s Rook I Project Emerges as a Key Source in the Next Uranium Supply Wave

MMCAP International increased its stake in NexGen Energy during the fourth quarter, deepening exposure to the company’s Rook I uranium project in Canada. As governments extend reactor lifespans and re...

news image

8개월 전 · Simply Wall St.

Drugs Made In America Acquisition II Corp. (NASDAQ:DMII) is largely controlled by institutional shareholders who own 79% of the company

Key Insights Institutions' substantial holdings in Drugs Made In America Acquisition II implies that they have...